These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7483307)

  • 1. Increasing doses of l-sulpiride reveal dose- and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogram.
    Stanzione P; Pierantozzi M; Semprini R; Tagliati M; Traversa R; Peppe A; Pierelli F; Bernardi G
    Vision Res; 1995 Sep; 35(18):2659-64. PubMed ID: 7483307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial frequency tuning of the monkey pattern ERG depends on D2 receptor-linked action of dopamine.
    Tagliati M; Bodis-Wollner I; Kovanecz I; Stanzione P
    Vision Res; 1994 Aug; 34(16):2051-7. PubMed ID: 7941404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease.
    Stanzione P; Traversa R; Pierantozzi M; Semprini R; Marciani MG; Bernardi G
    Neurosci Lett; 1992 Jun; 140(1):125-8. PubMed ID: 1407691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations.
    Stanzione P; Bodis-Wollner I; Pierantozzi M; Semprini R; Tagliati M; Peppe A; Bernardi G
    Clin Neurophysiol; 1999 Jan; 110(1):82-5. PubMed ID: 10348324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The push-pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptor ligands on the pattern electroretinogram.
    Bodis-Wollner I; Tzelepi A
    Vision Res; 1998 May; 38(10):1479-87. PubMed ID: 9667012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The visual system in Parkinson's disease.
    Bodis-Wollner I; Tagliati M
    Adv Neurol; 1993; 60():390-4. PubMed ID: 8420159
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of dopamine receptor blockade on the intensity-response function of ERG b- and d-waves in dark adapted eyes.
    Popova E; Kupenova P
    Vision Res; 2013 Aug; 88():22-9. PubMed ID: 23810982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning.
    Tagliati M; Bodis-Wollner I; Yahr MD
    Electroencephalogr Clin Neurophysiol; 1996 Jan; 100(1):1-11. PubMed ID: 8964257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial-frequency-dependent changes in the human pattern electroretinogram after acute acetyl-L-carnitine administration.
    Falsini B; Porciatti V; Bolzani R; Marchionni A
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):262-6. PubMed ID: 1869064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptor blockade differentially affects the light‑adapted turtle and frog electroretinogram.
    Popova E; Kupenova P
    Acta Neurobiol Exp (Wars); 2018; 78(4):332-342. PubMed ID: 30624432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease.
    Mehta MA; Sahakian BJ; McKenna PJ; Robbins TW
    Psychopharmacology (Berl); 1999 Sep; 146(2):162-74. PubMed ID: 10525751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.
    Zhao Y; Kerscher N; Eysel U; Funke K
    J Physiol; 2002 Feb; 539(Pt 1):223-38. PubMed ID: 11850515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern electroretinogram as a function of spatial frequency after retrobulbar optic neuritis.
    Falsini B; Bardocci A; Cermola S; Porciatti V; Porrello G
    Doc Ophthalmol; 1992; 79(4):325-36. PubMed ID: 1633744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulation of D2 receptors with quinpirole and sulpiride affects locomotor activity before spatial behavior of rats in an active place avoidance task.
    Stuchlik A; Rehakova L; Rambousek L; Svoboda J; Vales K
    Neurosci Res; 2007 Jun; 58(2):133-9. PubMed ID: 17360063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss?
    Peppe A; Stanzione P; Pierantozzi M; Semprini R; Bassi A; Santilli AM; Formisano R; Piccolino M; Bernardi G
    Electroencephalogr Clin Neurophysiol; 1998 Apr; 106(4):374-82. PubMed ID: 9741766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of background spatial contrast on electroretinographic responses in the human retina.
    Bodis-Wollner I; Brannan JR; Storch RL; Hajee ME; Minko M
    Vision Res; 2009 May; 49(9):922-30. PubMed ID: 18723047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the intravitreal administration of dopaminergic ligands on the b-wave amplitude of the rabbit electroretinogram.
    Huppé-Gourgues F; Coudé G; Lachapelle P; Casanova C
    Vision Res; 2005 Jan; 45(2):137-45. PubMed ID: 15581915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat.
    Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani AH
    Pharmacol Biochem Behav; 2002 Dec; 74(1):187-97. PubMed ID: 12376167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopamine D1 and D2 receptor antagonists on oral activity in rats.
    Levin ED; See RE; South D
    Pharmacol Biochem Behav; 1989 Sep; 34(1):43-8. PubMed ID: 2576312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens.
    David V; Durkin TP; Cazala P
    Psychopharmacology (Berl); 2002 Mar; 160(3):307-17. PubMed ID: 11889500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.